Zoetis is a Fortune 500 company in the world. It is an American veterinary pharmaceutical company dedicated to the development of animal COVID-19 vaccines. On December 9, 2022, Zoetis ranked 178th in the "2022 Hurun Global 500". In June 2023, it ranked 463rd on the 2023 Fortune 500 list with revenue of 8080 (million US dollars).
Zoetis is committed to providing users with complete veterinary pharmaceutical solutions. Currently, its product lines cover animal vaccines and deworming It has high visibility and reputation in the global market in the fields of medicines, antibiotics, diagnostic reagents, antiemetics, anesthesia, sedation, and antipruritic drugs.
